✦ LIBER ✦
The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity
✍ Scribed by Anthony E. Dear; Robert L. Medcalf
- Book ID
- 118564281
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 381 KB
- Volume
- 1492
- Category
- Article
- ISSN
- 0167-4781
No coin nor oath required. For personal study only.